CAS 99697-24-2
:Acido (3R)-3-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-diidrossi-10,13-dimetilesadecahidro-1H-ciclopenta[a]fenantren-17-il]butanoico
- Prezzo più basso
- Prezzo più alto
- Purezza più bassa
- Purezza più alta
- Consegna più veloce
24-Norursodeoxycholic acid
CAS:24-Norursodeoxycholic acid (nor-UDCA) is a Ursodeoxycholic Acid derivative. It has potent anti-inflammatory, anti-cholestatic, and anti-fibrotic properties.Formula:C23H38O4Purezza:99.69%Colore e forma:White SolidPeso molecolare:378.545424-Norursodeoxycholic acid
CAS:24-Norursodeoxycholic acidFormula:C23H38O4Purezza:99.5%Peso molecolare:378.55(3α,5β,7β)-3,7-Dihydroxy-24-norcholan-23-oic acid
CAS:Formula:C23H38O4Purezza:97%Colore e forma:SolidPeso molecolare:378.545424-Nor Ursodeoxycholic Acid
CAS:Prodotto controllatoApplications Ursodeoxycholic Acid (U850000) derivative. 24-norUrsodeoxycholic acid is superior to Ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice.
References Seedorf, U., et al.: J. Biol. Chem., 269, 21277 (1994), Stolowich, N., et al.: Biochemistry, 36, 1719 (1997),Formula:C23H38O4Colore e forma:NeatPeso molecolare:378.5524-Nor Ursodeoxycholic Acid-d5
CAS:Prodotto controllatoApplications Labelled Ursodeoxycholic Acid (U850000) derivative. 24-norUrsodeoxycholic acid is superior to Ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice.
References Seedorf, U., et al.: J. Biol. Chem., 269, 21277 (1994), Stolowich, N., et al.: Biochemistry, 36, 1719 (1997),Formula:C23D5H33O4Colore e forma:NeatPeso molecolare:383.576(R)-3-((3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-Dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)butanoic acid
CAS:Formula:C23H38O4Purezza:97%Peso molecolare:378.55Ref: 4Z-U-0228
5mgPrezzo su richiesta10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiesta24-Norursodeoxycholic acid
CAS:Prodotto controllato24-Norursodeoxycholic acid is a synthetic bile acid derivative, which is a modified form derived from natural bile acids. Its primary source is the chemical synthesis of ursodeoxycholic acid analogs. The mode of action involves modulating bile acid composition within the liver, thereby reducing cytotoxicity associated with bile acid accumulation. This modulation helps protect hepatocytes from damage, reducing liver inflammation and fibrosis.
Formula:C23H38O4Purezza:Min. 95%Colore e forma:PowderPeso molecolare:378.55 g/molRef: ST-EA-CP-U1017
10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiesta







